CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,929,830
- in 12 filings, $348K under 10b5-1 plans
Net +$2,318,700. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$747K Chief Medical Officer sold 45% of stake
- Powl Brian T. −$530K Chief Commercial Officer sold 34% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$192K Chief Operating Officer sold 14% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-24 | GUALBERTO ANTONIO Head of Development & CMO | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2018-01-24 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +275,000 | 275,000 | ||
| 2017-08-22 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +27,985 | $4.80 | $134K | 32,985 |
| 2017-08-22 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −27,985 | 92,015 | ||
| 2017-06-09 | Stein Steven H Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 | ||
| 2017-06-09 | Malley Thomas Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 | ||
| 2017-06-09 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 | ||
| 2017-06-09 | HOFFMAN ROBERT Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 | ||
| 2017-04-21 | WILSON TROY EDWARD President and CEO | Exercise or conversion | +5,000 | $4.80 | $24K | 5,000 |
| 2017-04-21 | WILSON TROY EDWARD President and CEO | Exercise or conversion · Option to purchase common stock | −5,000 | 120,000 | ||
| 2017-01-23 | LIU YI Chief Scientific Officer | Grant or award · Option to purchase common stock | +63,000 | 63,000 | ||
| 2017-01-23 | REN PINGDA SVP-Chemistry&Pharma Sciences | Grant or award · Option to purchase common stock | +55,000 | 55,000 | ||
| 2017-01-23 | North Annette SVP, General Counsel | Grant or award · Option to purchase common stock | +72,000 | 72,000 | ||
| 2017-01-23 | GUALBERTO ANTONIO Chief Medical Officer | Grant or award · Option to purchase common stock | +169,000 | 169,000 | ||
| 2017-01-23 | HENSON HEIDI Chief Financial Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2017-01-23 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +236,000 | 236,000 | ||
| 2017-01-03 | Stein Steven H Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2017-01-03 | Stein Steven H Director | Grant or award · Option to purchase common stock | +3,333 | 3,333 | ||
| 2016-05-12 | Malley Thomas Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 | ||
| 2016-05-12 | HOFFMAN ROBERT Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 |
Page 20 of 21 · 417 trades